| Followers | 12 |
| Posts | 1505 |
| Boards Moderated | 0 |
| Alias Born | 04/18/2016 |
Thursday, May 26, 2022 12:51:31 PM
Kaboom!!!
Recent CYTOF News
- Altamira Therapeutics Provides Business Update and Reports Full Year 2025 Financial Results • ACCESS Newswire • 03/31/2026 01:00:00 PM
- Altamira Therapeutics Announces Release Date for 2025 Annual Report and Financial Statements • ACCESS Newswire • 03/24/2026 01:00:00 PM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 02/27/2026 09:06:40 PM
- Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Bentrio Nasal Spray • ACCESS Newswire • 02/13/2026 02:00:00 PM
- Altamira Therapeutics to Present at mRNA-Based Therapeutics Summit • ACCESS Newswire • 01/23/2026 02:00:00 PM
- Altamira Therapeutics Announces Market Approval of Bentrio Nasal Spray in China • ACCESS Newswire • 12/19/2025 02:00:00 PM
- Altamira Therapeutics Announces Certification of Bentrio Nasal Spray under Medical Device Regulation • ACCESS Newswire • 11/20/2025 02:00:00 PM
- Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of DNA Molecules • ACCESS Newswire • 11/03/2025 02:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/29/2025 11:41:03 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/11/2025 08:15:01 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/09/2025 08:30:27 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 05/06/2025 10:39:06 AM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/30/2025 02:36:13 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/30/2025 12:00:02 PM
